CR7198A - Tableta que contiene cetirizina y pseudoefedrina - Google Patents

Tableta que contiene cetirizina y pseudoefedrina

Info

Publication number
CR7198A
CR7198A CR7198A CR7198A CR7198A CR 7198 A CR7198 A CR 7198A CR 7198 A CR7198 A CR 7198A CR 7198 A CR7198 A CR 7198A CR 7198 A CR7198 A CR 7198A
Authority
CR
Costa Rica
Prior art keywords
pseudoefedrine
tablet containing
containing cetirizine
cetirizine
relates
Prior art date
Application number
CR7198A
Other languages
English (en)
Inventor
Guichaux Anthony
Berwaer Monique
Deleers Michel
Fanara Domenico
Original Assignee
Jose Rogelio Perez Monsrreal
Dow Agrosciences Llc
Bridgestone Americas Tire
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26076635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR7198(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jose Rogelio Perez Monsrreal, Dow Agrosciences Llc, Bridgestone Americas Tire filed Critical Jose Rogelio Perez Monsrreal
Publication of CR7198A publication Critical patent/CR7198A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invencion se refiere a un comprimido que comprende dos segmentos distintos. Mas particularmente, la invencion se refiere a dos sustancias farmaceuticas y a procedimientos de tratamiento de trastornos alergicos.
CR7198A 2001-06-28 2003-12-11 Tableta que contiene cetirizina y pseudoefedrina CR7198A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30125001P 2001-06-28 2001-06-28
EP01115807 2001-06-28

Publications (1)

Publication Number Publication Date
CR7198A true CR7198A (es) 2008-07-29

Family

ID=26076635

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7198A CR7198A (es) 2001-06-28 2003-12-11 Tableta que contiene cetirizina y pseudoefedrina

Country Status (15)

Country Link
US (2) US7014867B2 (es)
JP (1) JP2007176958A (es)
KR (1) KR20090029314A (es)
AR (1) AR034866A1 (es)
BG (1) BG66269B1 (es)
CO (1) CO5540370A2 (es)
CR (1) CR7198A (es)
CY (1) CY1109238T1 (es)
DE (1) DE60232445D1 (es)
HK (1) HK1064596A1 (es)
HR (1) HRP20031057B1 (es)
IL (1) IL159287A0 (es)
MY (1) MY129643A (es)
NO (1) NO20035798L (es)
ZA (1) ZA200309720B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1467715B1 (en) * 2002-01-15 2010-11-03 Ucb Farchim S.A. Formulations for oral administration of active compounds
KR100754239B1 (ko) 2005-04-29 2007-09-03 주식회사 서울제약 염산세티리진과 염산슈도에페드린을 함유하는 제어방출성의 경구용 제제 및 그의 제조방법
WO2007141743A2 (en) * 2006-06-06 2007-12-13 Ranbaxy Laboratories Limited A tablet dosage form comprising cetirizine and pseudoephedrine
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
US8962022B2 (en) * 2007-03-27 2015-02-24 Aptalis Pharmatech, Inc. Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family
US8377475B2 (en) * 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
CA2748783A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
US8252330B2 (en) * 2009-01-05 2012-08-28 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
WO2011078993A1 (en) * 2009-12-21 2011-06-30 Aptapharma, Inc. Functionally-coated multilayer tablets
KR101193495B1 (ko) * 2010-02-01 2012-10-23 한미사이언스 주식회사 슈도에페드린 및 레보세티리진을 포함하는 경구용 복합 조성물
KR20130009553A (ko) * 2011-07-15 2013-01-23 한미약품 주식회사 몬테루카스트 또는 이의 약학적으로 허용가능한 염 및 레보세티리진 또는 이의 약학적으로 허용가능한 염을 함유하는 캡슐 제제
JP2020015690A (ja) * 2018-07-25 2020-01-30 ニプロ株式会社 レボセチリジン含有錠剤
US11701350B2 (en) 2019-07-22 2023-07-18 L. Perrigo Company Dextromethorphan extended release pharmaceutical composition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783465A (en) 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
JPH0794379B2 (ja) * 1990-08-07 1995-10-11 ファイザー・インコーポレーテッド 放出製剤における界面重合膜の使用方法
HUT75616A (en) 1992-03-17 1997-05-28 Pfizer Method for prooucing porous delivery devices
CA2128820A1 (en) * 1993-07-27 1995-01-28 Walter G. Gowan, Jr. Rapidly disintegrating pharmaceutical dosage form and process for preparation thereof
EP0841947A1 (en) 1995-07-28 1998-05-20 The Procter & Gamble Company Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
US6469009B1 (en) * 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US6471992B1 (en) * 1997-02-20 2002-10-29 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
BE1011045A3 (fr) 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
DE19716907A1 (de) 1997-04-22 1998-11-05 Siemens Ag Regelung für ein Hochleistungsförderband im industriellen Einsatz
US6027746A (en) * 1997-04-23 2000-02-22 Warner-Lambert Company Chewable soft gelatin-encapsulated pharmaceutical adsorbates
ID26390A (id) 1997-12-23 2000-12-21 Schering Corp Komposisi untuk pengobatan pernapasan dan penyakit kulit sekurangnya terdiri dari satu leukotrien antagonis dan satu antihistamin
US6270790B1 (en) * 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6521254B2 (en) * 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6267986B1 (en) * 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
ATE330586T1 (de) 2001-03-14 2006-07-15 Pfizer Prod Inc Pharmazeutische tablette und eine verfahren zu deren herstellung
EP1241110A1 (en) 2001-03-16 2002-09-18 Pfizer Products Inc. Dispensing unit for oxygen-sensitive drugs
WO2002096392A1 (en) 2001-05-31 2002-12-05 Cima Labs Inc. Taste-masking of highly water-soluble drugs
EE05357B1 (et) * 2001-06-28 2010-12-15 Ucb, Farchim, S.A. Tablett, mis sisaldab v„hemalt kahte eristatavat segmenti, ning selle kasutamine

Also Published As

Publication number Publication date
HK1064596A1 (en) 2005-02-04
AR034866A1 (es) 2004-03-24
IL159287A0 (en) 2004-06-01
KR20090029314A (ko) 2009-03-20
DE60232445D1 (de) 2009-07-09
HRP20031057A2 (en) 2005-10-31
JP2007176958A (ja) 2007-07-12
US20060034928A1 (en) 2006-02-16
BG66269B1 (bg) 2012-11-30
US7014867B2 (en) 2006-03-21
HRP20031057B1 (hr) 2013-05-31
MY129643A (en) 2007-04-30
NO20035798L (no) 2004-02-27
US7226614B2 (en) 2007-06-05
BG108452A (en) 2005-02-28
CO5540370A2 (es) 2005-07-29
CY1109238T1 (el) 2014-07-02
US20040170690A1 (en) 2004-09-02
ZA200309720B (en) 2005-02-23

Similar Documents

Publication Publication Date Title
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
DE60235083D1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
ATE302600T1 (de) Arzneimittel auf basis von tramadol
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
MA27018A1 (fr) Forme dosifiee pharmaceutique de mesylate de nelfinavir amorphe.
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
BR0315296A (pt) Derivados do ciclohexanol espirocìclicos
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
DE60333294D1 (de) Kontrollierte verabreichung von arzneien
NO20034056D0 (no) Proliferative sykdommer
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
CY1109238T1 (el) Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
ATE432068T1 (de) Cetirizin und pseudoephedrin enthaltende tablette
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
ATE344223T1 (de) Vitamin d-analoge
ATE402158T1 (de) Flavonoid-derivat
RS50523B (sr) Farmaceutska kompozicija koja sadrži cink-hijaluronat kompleks za lečenje multiple skleroze
RS50681B (sr) Kombinacija taksana i ciklin-zavisne kinaze
DE60322577D1 (de) Tablette enthaltend efletirizin und pseudoephedrin
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
EA200500538A1 (ru) Фармацевтическое средство для эндоназального применения при лечении болезней и нарушений нервной системы
DE60122764D1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen

Legal Events

Date Code Title Description
FC Refusal